 |
인쇄하기
취소
|
MSD's Gardasil soon to launch far ahead of GSK's Cervarix.
GSK and MSD may compete with the cervical cancer vaccine, called Cervarix and Gardasil.
However, MSD Korea already got the KFDA approval of Gardasil for the market launching in coming Sept, far ahead to GSK's Cervaris.
MSD Korea said "All vaccines should be examined by the health authority prior to the market release, taking about 2 to 3 months, and therefore Gardasil may be available to ...
However, MSD Korea already got the KFDA approval of Gardasil for the market launching in coming Sept, far ahead to GSK's Cervaris.
MSD Korea said "All vaccines should be examined by the health authority prior to the market release, taking about 2 to 3 months, and therefore Gardasil may be available to ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.